The cough hypersensitivity syndrome global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cough Hypersensitivity Syndrome Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The cough hypersensitivity syndrome market size has grown strongly in recent years. It will grow from $9.71 billion in 2023 to $10.36 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased awareness, telemedicine and remote monitoring, public health initiatives, research funding.
The cough hypersensitivity syndrome market size is expected to see strong growth in the next few years. It will grow to $13.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to global health access, patient advocacy and support, quality of life improvements. Major trends in the forecast period include improved diagnosis and screening tools, personalized treatment approaches, new medications.
Order your report now for swift delivery @
Scope Of Cough Hypersensitivity Syndrome Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Cough Hypersensitivity Syndrome Market Overview
Market Drivers –
The rising prevalence of chronic respiratory diseases is expected to propel the growth of the cough hypersensitivity syndrome market going forward. Chronic respiratory diseases (CRDs) refer to a group of long-term diseases that affect the airways and lungs, leading to persistent breathing difficulties and reduced lung function over time. Cough hypersensitivity syndrome treatment reduces discomfort, enhances respiratory health, thereby improving the quality of life for patients suffering from chronic respiratory diseases such as asthma. For instance, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based national agency, almost one-third (30%) of the Australian population, that is, 7.5 million people, are suffering from chronic respiratory diseases. Additionally, in June 2023, according to the Centers for Disease Control and Prevention, a US-based public health agency, there were 142,342 deaths from chronic lower respiratory diseases in 2021. Therefore, the rising prevalence of chronic respiratory diseases drives the cough hypersensitivity syndrome market.
Market Trends –
Major companies operating in the cough hypersensitivity syndrome market are adopting AI-powered algorithms to sustain their position in the market. AI-powered algorithms refer to computational processes and procedures that utilize artificial intelligence (AI) techniques to perform tasks or solve problems. For instance, in April 2021, NuvoAir, a US-based digital healthcare company, launched NuvoAir Cough, a mobile app for detecting cough hypersensitivity syndrome. This is a smartphone app that tracks coughs in domestic settings and is accessible for the iOS operating system. It detects a single cough or burst of coughs using the smartphone’s microphone and an artificial intelligence (AI)-powered algorithm. The AI algorithm separates coughs from other sounds using the recorded sound and provides the results back to the user and their clinical physician.
The cough hypersensitivity syndrome market covered in this report is segmented –
1) By Drug Class: Inhales Corticosteroids; Antitussive Agents; Short-acting Beta-2 Agonists; Anticholinergics; Proton Pump Inhibitors; Antihistamines; Other Drugs
2) By Route of Administration: Oral; Inhalation; Other Route Of Administration
3) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
Get an inside scoop of the cough hypersensitivity syndrome market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12989&type=smp
Regional Insights –
North America was the largest region in the cough hypersensitivity syndrome market in 2023. The regions covered in cough hypersensitivity syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the cough hypersensitivity syndrome market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck and Co Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Wyeth Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Mylan N.V., Lupin Limited, Cadila Pharmaceuticals, Almirall S.A., Akorn Operating Company LLC, Kudco Ireland Ltd., Prestige Consumer Healthcare Inc., GMP Laboratories of America Inc., The Betty Mills Company, Acura Pharmaceuticals Inc.
Table of Contents
- Executive Summary
- Cough Hypersensitivity Syndrome Market Report Structure
- Cough Hypersensitivity Syndrome Market Trends And Strategies
- Cough Hypersensitivity Syndrome Market – Macro Economic Scenario
- Cough Hypersensitivity Syndrome Market Size And Growth
…..
- Cough Hypersensitivity Syndrome Market Competitor Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
